Sandra E. Rowland - 27 Feb 2023 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: SVP & CFO
Issuer ticker: XYL
Reported as of: 27 Feb 2023
Net transaction value: -$351,644
SEC form: 4
Accepted by SEC: 28 Feb 2023, 18:31:10 UTC
Prior SEC filing: 03 Mar 2022
Next SEC filing: 03 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Callie Plant, by power of attorney for Sandra E. Rowland

Key filing fact

Sandra E. Rowland filed Form 4 for Xylem Inc. (XYL) on 28 Feb 2023.

Key facts

This page summarizes Sandra E. Rowland's Form 4 filing for Xylem Inc. (XYL).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Feb 2023, 18:31.

Change

Previous filing in this sequence was filed on 03 Mar 2022.
Current net transaction value: -$351,644.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $0
Shares: +7,819
Change %: +64%
Price: $0.000000
Shares after: 20,088
Date: 27 Feb 2023
Ownership: Direct
Footnotes: F1, F2

XYL transaction

Common Stock

Tax liability

Transaction value: $291,345
Shares: -2,841
Change %: -14%
Price: $102.55
Shares after: 17,247
Date: 27 Feb 2023
Ownership: Direct
Footnotes: F3

XYL transaction

Common Stock

Tax liability

Transaction value: $60,299
Shares: -588
Change %: -3.4%
Price: $102.55
Shares after: 16,659
Date: 27 Feb 2023
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects shares of common stock earned upon vesting of performance-based restricted stock units granted November 2, 2020 upon achievement of performance criteria related to Total Shareholder Return.

Footnote F2

Includes additional shares due to dividend reinvestment.

Footnote F3

Reflects units withheld to pay the tax liability incident to the vesting of performance-based restricted stock units granted on November 2, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Footnote F4

Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on November 2, 2020 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).